Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2017 May 15.

Published in final edited form as: Toxicol Appl Pharmacol. 2016 Feb 20;299:125–131. doi: 10.1016/j.taap.2016.02.016

Table 2.

The content of the cytokines/proteins in serum and sputum samples in exposure and control groups.

Cytokines/proteins, pg/ml	Sputum		Serum

	Control	Exposed group	Control	Exposed group
IL-1β	646.90 ± 188.18	1988.70 ± 205.71^*	36.61 ± 3.86	90.08 ± 23.29^*
IL-4	299.33 ± 108.77	818.86 ± 57.34^*	19.46 ± 8.30	47.38 ± 6.30^*
Il-5	436.43 ± 173.40	1764.37 ± 424.12^*	15.24 ± 2.83	22.02 ± 3.77
Il-6	47.98 ± 40.79	262.75 ± 22.34^*
IL-8	863.84 ± 222.37	1753.51 ± 201.91^*	769.87 ± 214.95	1217.98 ± 237.00
TNF-α	321.41 ± 156.34	1512.67 ± 271.88^*	20.98 ± 3.66	52.47 ± 9.19^*
IL-10			8.40 ± 3.24	18.05 ± 0.41^*
Il-2	374.16 ± 128.07	887.59 ± 354.36	80.62 ± 12.73	88.70 ± 3.92
IFN-γ	992.15 ± 510.59	2635.29 ± 958.51	19.47 ± 5.12	29.15 ± 1.47
IL-12			11.14 ± 2.26	17.37 ± 0.72
KL-6	12.20 ± 8.69	220.50 ± 95.06^*	248.35 ± 37.81	313.52 ± 29.46
TGF-β1	4.90 ± 0.34	5.0 ± 0.95	20.06 ± 0.31	21.82 ± 1.23
Osteopontin			59.19 ± 5.37	68.98 ± 7.20

^*

p < 0.05, t-test.